18 Biggest Mid-Day Gainers For Wednesday

Loading...
Loading...
  • Orexigen Therapeutics, Inc. OREX shares surged 44.3 percent to $2.99 after the company announced a new ad campaign that will launch this week called 'Brains Behind Weight Loss'.
  • CymaBay Therapeutics Inc CBAY shares climbed 33.7 percent to $2.54 after the company reported a licensing deal with Kowa Pharmaceuticals America, Inc. for exclusive US rights to arhalofenate.
  • Evoke Pharma Inc EVOK shares jumped 27 percent to $2.63. Evoke Pharma disclosed that Phase 3 Gimoti trial failed to reach its primary endpoint. However, the company announced that 51 percent of patients responded better to Gimoti than placebo.
  • Merus NV MRUS shares gained 22.9 percent to $25.90.
  • PhotoMedex Inc PHMD shares rose 22.1 percent to $2.97. PhotoMedex shares have increased 10.45 percent over the past 52 weeks, while the S&P 500 index has gained 12.18 percent in the same period.
  • O2Micro International Limited (ADR) OIIM shares surged 21.5 percent to $2.30 after the company revised its Q4 financial guidance. O2Micro raised its Q4 revenue guidance from $14.7 million-$15.6 million to $15.4 million-$15.9 million.
  • Weight Watchers International, Inc. WTW climbed 19.2 percent to $13.21.
  • ImmunoGen, Inc. IMGN shares rose 18 percent to $2.45 after gaining 1.96 percent on Tuesday.
  • Shake Shack Inc SHAK gained 7.7 percent to $38.90. Shake Shack will replace Chemours in the S&P SmallCap 600 after the close of trading on January 4.
  • Partner Communications Company Ltd (ADR) PTNR shares rose 6.8 percent to $5.43 after gaining 8.42 percent on Tuesday.
  • Encana Corp (USA) ECA shares rose 6.2 percent to $12.68 in pre-market trading. Ecana is expecting 2017 corporate margin to be greater than $10 per barrel of oil equivalent.
  • Chemours Co CC shares gained 6.2 percent to $22.53. Chemours will replace IDEXX Laboratories, Inc. IDXX in the S&P MidCap 400 after the close of trading on January 4.
  • Nivalis Therapeutics Inc NVLS shares rose 5.2 percent to $2.32. Nivalis Therapeutics disclosed that it is exploring strategic alternatives for the company and has engaged Ladenburg Thalmann to act as an advisor.
  • Abercrombie & Fitch Co. ANF gained 5.1 percent to $12.73. FBR Capital upgraded Abercrombie & Fitch from Underperform to Market Perform.
  • Fusion Telecommunications Int'l, Inc. FSNN surged 4.7 percent to $1.52. Craig-Hallum initiated coverage on Fusion Telecommunications with a Buy rating.
  • Global Blood Therapeutics Inc GBT rose 4.2 percent to $14.90. JPMorgan initiated coverage on Global Blood Therapeutics with an Overweight rating.
  • Achaogen Inc AKAO rose 4.1 percent to $13.53. Leerink Swann initiated coverage on Achaogen with an Outperform rating.
  • Aecom ACM gained 3.4 percent to $38.26. Baird upgraded Aecom from Neutral to Outperform.
Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: NewsIntraday UpdateMarketsAnalyst RatingsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...